PARP1 and cancer: Small nucleolar RNAs (snoRNAs) were also reported as important DNA damage-independent activators of PARP-1 activity in the control of ribosome biogenesis (112), a pathway that may contribute to the effectiveness of PARPi in the treatment of a number of cancer types (113,114).